Table of Contents Table of Contents
Previous Page  609 / 1084 Next Page
Information
Show Menu
Previous Page 609 / 1084 Next Page
Page Background

38

STO3 Trial

Perioperative ECX +/- bevacizumab in patients with

gastric or oesophagogastric junction adenocarcinoma

Cunningham et al 2017, Lancet Oncol. 18: 357-70